MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

RadNet Stock

RadNet, Inc.

RDNTNASDAQMarkt
US$68.80
-2.3% today

Company data

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
United States
CEO
Howard G. Berger
Employees
9,060
Market cap
$5.4 B
IPO
03/01/1997

RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

RadNet stock: price history

16/10/25-11.1 %16/10/26

1D

-2.3%

1W

-3.0%

1M

-9.2%

6M

+13.9%

YTD

-3.6%

1Y

-11.1%

2Y

-2.2%

5Y

+139.1%

10Y

+818.6%

Next earnings date

Next earnings date

09/11/2026 (in 23 days)

Volatility around earnings

~26% stronger price swings than usual

Pattern chart

Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 14/10/26. Not a buy or sell signal.Beta

What does this mean?

Double top

Bearish

The price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.

Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.

Ask the agents about RadNet

Analyst assessment of RadNet

PRICE TARGET LOW

US$65.00

CONSENSUS

US$65.00

MEDIAN

US$65.00

PRICE TARGET HIGH

US$65.00

1

STRONG BUY

8

BUY

2

HOLD

0

SELL

0

STRONG SELL

11

TOTAL · Buy

As of: 28/08/2026

ANALYST FIRMRATINGACTIONDATE
BarclaysOverweightmaintain28/08/2026
Truist SecuritiesBuymaintain11/08/2026
BarclaysOverweightmaintain20/05/2026
BarclaysOverweightmaintain21/04/2026
B. Riley SecuritiesBuymaintain01/12/2025
BarclaysOverweightmaintain13/11/2025
Truist SecuritiesBuymaintain12/11/2025
Truist SecuritiesBuymaintain03/09/2025 (older than 12 months)

RadNet stock metrics

P/E

-258.16

P/B

4.88

EV/EBITDA

24.77

RETURN ON EQUITY

0.7%

NET MARGIN

1.2%

DEBT/EQUITY

1.99

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

89.5%

FLOAT SHARES

70,416,824

AVG. DAILY VOLUME (30D)

673,095

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

SWARTZ DAVID L

DirectorSale2,69953.89Spontaneous22/06/2026

Berger Howard G

OfficerGift90–Spontaneous18/06/2026

Wesdorp Cornelis

OfficerSale4,75058.11Spontaneous18/06/2026

Forthuber Stephen M

OfficerSale24,21457.79Spontaneous16/06/2026

Forthuber Stephen M

OfficerSale19,85358.61Spontaneous16/06/2026
Page 1 / 2

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC19,833+14,71330/09/2026
Gradient Investments LLC19,490-1,53830/09/2026
State of Alaska, Department of Revenue15,572-12,04230/09/2026
INDEPENDENT FINANCIAL GROUP, LLC14,866+14,86630/09/2026
FULTON BANK, N.A.9,150-86430/09/2026
Page 1 / 3

Dividends & Stock splits

DATERATIO
28/11/20061:2

Comparable stocks

Frequently asked questions about RadNet stock

What does RadNet do?

RadNet, Inc. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.

The CEO is Howard G. Berger, the company employs around 9,060 people.

The IPO was on 03/01/1997; the stock trades on NASDAQ under the ticker RDNT.

What do analysts say about RadNet stock?

11 analysts rate the stock, the consensus is Buy (as of 28/08/2026).

The average price target is US$65.00, ranging from US$65.00 to US$65.00, with a median of US$65.00.

This is an external assessment, not a statement by Market Jury.

When does RadNet report next?

The next earnings date is 09/11/2026.

Around past earnings, price swings were roughly 26% stronger than usual.

Does RadNet pay a dividend?

No, RadNet currently does not pay a dividend.

Which stocks are comparable to RadNet?

Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.

How can I get RadNet stock analyzed?

Clicking "Analyze stock" lets five strategies assess RadNet against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.